Role of endogenous digitalis-like factors in the clinical manifestations of severe preeclampsia: a sytematic review.

Abstract

Endogenous digitalis-like factor(s), originally proposed as a vasoconstrictor natriuretic hormone, was discovered in fetal and neonatal blood accidentally because it cross-reacts with antidigoxin antibodies (ADAs). Early studies using immunoassays with ADA identified the digoxin-like immuno-reactive factor(s) (EDLF) in maternal blood as well, and suggested it originated in the feto-placental unit. Mammalian digoxin-like factors have recently been identified as at least two classes of steroid compounds, plant derived ouabain (O), and several toad derived bufodienolides, most prominent being marinobufagenin (MBG). A synthetic pathway for MBG has been identified in mammalian placental tissue. Elevated maternal and fetal EDLF, O and MBG have been demonstrated in preeclampsia (PE), and inhibition of red cell membrane sodium, potassium ATPase (Na, K ATPase (NKA)) by EDLF is reversed by ADA fragments (ADA-FAB). Accordingly, maternal administration of a commercial ADA-antibody fragment (FAB) was tested in several anecdotal cases of PE, and two, small randomized, prospective, double-blind clinical trials. In the first randomized trial, ADA-FAB was administered post-partum, in the second antepartum. In the post-partum trial, ADA-FAB reduced use of antihypertensive drugs. In the second trial, there was no effect of ADA-FAB on blood pressure, but the fall in maternal creatinine clearance (CrCl) was prevented. In a secondary analysis using the pre-treatment maternal level of circulating Na, K ATPase (NKA) inhibitory activity (NKAI), ADA-FAB reduced the incidence of pulmonary edema and, unexpectedly, that of severe neonatal intraventricular hemorrhage (IVH). The fall in CrCl in patients given placebo was proportional to the circulating level of NKAI. The implications of these findings on the pathophysiology of the clinical manifestations PE are discussed, and a new model of the respective roles of placenta derived anti-angiogenic (AAG) factors (AAGFs) and EDLF is proposed.

• Authors: Vardaman M Buckalew
• Journal: Clinical science (London, England : 1979) (Clin Sci (Lond)) Vol. 132 Issue 12 Pg. 1215-1242 (06 29 2018) ISSN: 1470-8736 [Electronic] England
• PMID: 29930141 (Publication Type: Journal Article, Systematic Review)
• Copyright: © 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Chemical References

• Cardenolides
• Saponins
• digoxin-like factors
• Ouabain

Topics

• Birth Weight (physiology)
• Blood Pressure (physiology)
• Cardenolides (metabolism)
• Female
• Fetal Blood (metabolism)
• Gestational Age
• Humans
• Infant, Newborn
• Ouabain (metabolism)
• Placenta (metabolism)
• Pre-Eclampsia (metabolism, physiopathology)
• Pregnancy
• Saponins (metabolism)